Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gaudium IVF And Women HealthNSE:GAUDIUMIVF +4.99%20 ROA % is 17.31% as of Mar. 2026, which is 37% below its 10-year median of 27.49. GuruFocus rates NSE:GAUDIUMIVF with a GF Score™ of 20/100. The stock has 5 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Gaudium IVF And Women Health ranks better than 83.89% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Gaudium IVF And Women Health's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹334.3 Mil.
Gaudium IVF And Women Health's average Total Assets over the quarter that ended in Mar. 2026 was ₹1,931.0 Mil. Therefore, Gaudium IVF And Women Health's annualized ROA % for the quarter that ended in Mar. 2026 was 17.31%.
The historical rank and industry rank for Gaudium IVF And Women Health's ROA % or its related term are showing as below:
NSE:GAUDIUMIVF'
s ROA % Range Over the Past 10 Years
Min: 9.26 Med: 27.49 Max: 49.73
Current: 9.26
During the past 5 years, Gaudium IVF And Women Health's highest ROA % was 49.73%. The lowest was 9.26%. And the median was 27.49%.
NSE:GAUDIUMIVF's ROA % is ranked better than 83.89% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.79
vs NSE:GAUDIUMIVF: 9.26
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Gaudium IVF And Women Health ROA % Related Terms
Gaudium IVF And Women Health ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Gaudium IVF And Women Health's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gaudium IVF And Women Health ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gaudium IVF And Women Health's ROA % distribution charts can be found below:
* The bar in red indicates where Gaudium IVF And Women Health's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a ROA % of 17.31% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Gaudium IVF And Women Health and its competitors. This is 37% below median its historical median of 27.49. Over the past decade, Gaudium IVF And Women Health's ROA % has ranged from 9.26 to 49.73. According to the industry distribution chart, Gaudium IVF And Women Health ranks #110 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 16.1%.
Is Gaudium IVF And Women Health's ROA % too high?
Gaudium IVF And Women Health's current ROA % of 17.31% is 37% below median its 10-year median of 27.49. Over the past 10 years, this metric has ranged from a low of 9.26 to a high of 49.73. The Healthcare Providers & Services industry median ROA % is 1.79. Gaudium IVF And Women Health's value of 17.31% is 867% above this industry median. Based on the distribution chart, Gaudium IVF And Women Health ranks #110 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Gaudium IVF And Women Health has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Gaudium IVF And Women Health's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gaudium IVF And Women Health ranks #110 out of 683 companies for ROA %. This places Gaudium IVF And Women Health in the top 16% of its industry — outperforming the majority of peers. The industry median ROA % is 1.79. Gaudium IVF And Women Health's value of 17.31% is 867% above this benchmark. Historically, Gaudium IVF And Women Health's own ROA % has ranged from 9.26 to 49.73 over the past decade. While the company's 10-year median is 27.49 vs. the industry median of 1.79, Gaudium IVF And Women Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.79, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gaudium IVF And Women Health's current ROA % of 17.31% is 867% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Gaudium IVF And Women Health and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gaudium IVF And Women Health's current ROA % is 17.31%, which is 37% below median its own 10-year median of 27.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaudium IVF And Women Health stock overvalued right now?
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a current ROA % of 17.31%. The current ROA % is 17.31%, which is 37% below median its 10-year median of 27.49 and 867% above the Healthcare Providers & Services industry median of 1.79. Gaudium IVF And Women Health's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Gaudium IVF And Women Health (NSE:GAUDIUMIVF), the current ROA % is 17.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gaudium IVF And Women Health Ltd is engaged in the business of providing healthcare services mainly rendering various fertility treatments such as In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Intracytoplasmic Sperm Injection (ICSI), Egg Freezing, and laser assisted embryo implantation, amongst others. The company derives the majority of its revenue from business of providing IVF treatment in bundled packages which includes injections, Ovum/Egg Pickup, Embryo Creation and Embryo Transfer.
20GF Score
Get the complete analysis for NSE:GAUDIUMIVF
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GAUDIUMIVF has been successfully added to your 
